APO Research
Talk to an analyst

APO RESEARCH · REPORT

Osimertinib Generics

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Osimertinib Generics Market Outlook and Growth Opportunities 2026

27 December 2025196 pages

Choose your research edition.

Industry ResearchOsimertinib Generics Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Osimertinib Generics Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Osimertinib Generics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Osimertinib Generics Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Osimertinib Generics Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Osimertinib Generics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Osimertinib Generics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Osimertinib Generics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Osimertinib Generics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Osimertinib Generics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Osimertinib Generics market include Beacon, Drug International, General Pharmaceuticals, Pharmacil, Zydus and Wanbang Biopharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Osimertinib Generics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Osimertinib Generics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Osimertinib Generics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Osimertinib Generics market size, projected growth trends, production technologies, key applications, and end-use industries.

Osimertinib Generics Segment by Company

Beacon

Drug International

General Pharmaceuticals

Pharmacil

Zydus

Wanbang Biopharmaceuticals

Osimertinib Generics Segment by Type

40mg per Tablet

80mg per Tablet

Osimertinib Generics Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Osimertinib Generics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Osimertinib Generics status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Osimertinib Generics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Osimertinib Generics significant trends, drivers, influence factors in global and regions.

6. To analyze Osimertinib Generics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Osimertinib Generics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Osimertinib Generics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Osimertinib Generics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Osimertinib Generics market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Osimertinib Generics industry.

Chapter 3: Detailed analysis of Osimertinib Generics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Osimertinib Generics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Osimertinib Generics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Osimertinib Generics Industry Trends Table 2. Osimertinib Generics Industry Drivers Table 3. Osimertinib Generics Industry Opportunities and Challenges Table 4. Osimertinib Generics Industry Restraints Table 5. Global Osimertinib Generics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Osimertinib Generics Revenue Share by Company (2021-2026) Table 7. Global Osimertinib Generics Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Osimertinib Generics Sales Volume Share by Company (2021-2026) Table 9. Global Osimertinib Generics Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Osimertinib Generics Company Ranking, (2024-2026) & (USD Million) Table 11. Global Osimertinib Generics Key Company Manufacturing Base & Headquarters Table 12. Global Osimertinib Generics Company, Product Type & Application Table 13. Global Osimertinib Generics Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Osimertinib Generics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 40mg per Tablet Table 18. Significant Companies of 80mg per Tablet Table 19. Global Osimertinib Generics Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Osimertinib Generics Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Osimertinib Generics Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Osimertinib Generics Sales Volume Share by Type (2021-2026) Table 23. Global Osimertinib Generics Sales Volume Share by Type (2027-2032) Table 24. Global Osimertinib Generics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Osimertinib Generics Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Osimertinib Generics Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Osimertinib Generics Sales Value Share by Type (2021-2026) Table 28. Global Osimertinib Generics Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital and Clinic Table 30. Significant Companies of Retail Pharmacies Table 31. Significant Companies of Other Table 32. Global Osimertinib Generics Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Osimertinib Generics Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Osimertinib Generics Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Osimertinib Generics Sales Volume Share by Application (2021-2026) Table 36. Global Osimertinib Generics Sales Volume Share by Application (2027-2032) Table 37. Global Osimertinib Generics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Osimertinib Generics Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Osimertinib Generics Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Osimertinib Generics Sales Value Share by Application (2021-2026) Table 41. Global Osimertinib Generics Sales Value Share by Application (2027-2032) Table 42. Global Osimertinib Generics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Osimertinib Generics Sales by Region (2021-2026) & (K Units) Table 44. Global Osimertinib Generics Sales Market Share by Region (2021-2026) Table 45. Global Osimertinib Generics Sales by Region (2027-2032) & (K Units) Table 46. Global Osimertinib Generics Sales Market Share by Region (2027-2032) Table 47. Global Osimertinib Generics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Osimertinib Generics Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Osimertinib Generics Sales Value Share by Region (2021-2026) Table 50. Global Osimertinib Generics Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Osimertinib Generics Sales Value Share by Region (2027-2032) Table 52. Global Osimertinib Generics Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Osimertinib Generics Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Osimertinib Generics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Osimertinib Generics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Osimertinib Generics Sales by Country (2021-2026) & (K Units) Table 57. Global Osimertinib Generics Sales Market Share by Country (2021-2026) Table 58. Global Osimertinib Generics Sales by Country (2027-2032) & (K Units) Table 59. Global Osimertinib Generics Sales Market Share by Country (2027-2032) Table 60. Global Osimertinib Generics Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Osimertinib Generics Sales Value Market Share by Country (2021-2026) Table 62. Global Osimertinib Generics Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Osimertinib Generics Sales Value Market Share by Country (2027-2032) Table 64. Beacon Company Information Table 65. Beacon Business Overview Table 66. Beacon Osimertinib Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Beacon Osimertinib Generics Product Portfolio Table 68. Beacon Recent Development Table 69. Drug International Company Information Table 70. Drug International Business Overview Table 71. Drug International Osimertinib Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Drug International Osimertinib Generics Product Portfolio Table 73. Drug International Recent Development Table 74. General Pharmaceuticals Company Information Table 75. General Pharmaceuticals Business Overview Table 76. General Pharmaceuticals Osimertinib Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. General Pharmaceuticals Osimertinib Generics Product Portfolio Table 78. General Pharmaceuticals Recent Development Table 79. Pharmacil Company Information Table 80. Pharmacil Business Overview Table 81. Pharmacil Osimertinib Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Pharmacil Osimertinib Generics Product Portfolio Table 83. Pharmacil Recent Development Table 84. Zydus Company Information Table 85. Zydus Business Overview Table 86. Zydus Osimertinib Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Zydus Osimertinib Generics Product Portfolio Table 88. Zydus Recent Development Table 89. Wanbang Biopharmaceuticals Company Information Table 90. Wanbang Biopharmaceuticals Business Overview Table 91. Wanbang Biopharmaceuticals Osimertinib Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Wanbang Biopharmaceuticals Osimertinib Generics Product Portfolio Table 93. Wanbang Biopharmaceuticals Recent Development Table 94. Key Raw Materials Table 95. Raw Materials Key Suppliers Table 96. Osimertinib Generics Distributors List Table 97. Osimertinib Generics Customers List Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Osimertinib Generics Product Image Figure 2. Global Osimertinib Generics Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Osimertinib Generics Sales Value (2021-2032) & (US$ Million) Figure 4. Global Osimertinib Generics Sales (2021-2032) & (K Units) Figure 5. Global Osimertinib Generics Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Osimertinib Generics Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 40mg per Tablet Image Figure 10. 80mg per Tablet Image Figure 11. Global Osimertinib Generics Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Osimertinib Generics Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Osimertinib Generics Sales Volume Share by Type (2021-2032) Figure 14. Global Osimertinib Generics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Osimertinib Generics Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Osimertinib Generics Sales Value Share by Type (2021-2032) Figure 17. Hospital and Clinic Image Figure 18. Retail Pharmacies Image Figure 19. Other Image Figure 20. Global Osimertinib Generics Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Osimertinib Generics Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Osimertinib Generics Sales Volume Share by Application (2021-2032) Figure 23. Global Osimertinib Generics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Osimertinib Generics Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Osimertinib Generics Sales Value Share by Application (2021-2032) Figure 26. Global Osimertinib Generics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Osimertinib Generics Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Osimertinib Generics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Osimertinib Generics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Osimertinib Generics Sales Value (2021-2032) & (US$ Million) Figure 31. North America Osimertinib Generics Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Osimertinib Generics Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Osimertinib Generics Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Osimertinib Generics Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Osimertinib Generics Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Osimertinib Generics Sales Value (2021-2032) & (US$ Million) Figure 37. South America Osimertinib Generics Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Osimertinib Generics Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Osimertinib Generics Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Osimertinib Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Osimertinib Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Osimertinib Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Osimertinib Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Osimertinib Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Osimertinib Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Osimertinib Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Osimertinib Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Osimertinib Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Osimertinib Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Osimertinib Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Osimertinib Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Osimertinib Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Osimertinib Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Osimertinib Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Osimertinib Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Osimertinib Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Osimertinib Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Osimertinib Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Osimertinib Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Osimertinib Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Osimertinib Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Osimertinib Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Osimertinib Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Osimertinib Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Osimertinib Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Osimertinib Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Osimertinib Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Osimertinib Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Osimertinib Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Osimertinib Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Osimertinib Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Osimertinib Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Osimertinib Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Osimertinib Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Osimertinib Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Osimertinib Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Osimertinib Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Osimertinib Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Osimertinib Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Osimertinib Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Osimertinib Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Osimertinib Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Osimertinib Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Osimertinib Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Osimertinib Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Osimertinib Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Osimertinib Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Osimertinib Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Osimertinib Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Osimertinib Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Osimertinib Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Osimertinib Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Osimertinib Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Osimertinib Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Osimertinib Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Osimertinib Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Osimertinib Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Osimertinib Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Osimertinib Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Osimertinib Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Osimertinib Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Osimertinib Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Osimertinib Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Osimertinib Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Osimertinib Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Osimertinib Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Osimertinib Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Osimertinib Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Osimertinib Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Osimertinib Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Osimertinib Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Osimertinib Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Osimertinib Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Osimertinib Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Osimertinib Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Osimertinib Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Osimertinib Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Osimertinib Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Osimertinib Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Osimertinib Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Osimertinib Generics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Osimertinib Generics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Osimertinib Generics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Osimertinib Generics Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Osimertinib Generics Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 40mg per Tablet
  • 80mg per Tablet
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Beacon
  • Drug International
  • General Pharmaceuticals
  • Pharmacil
  • Zydus
  • Wanbang Biopharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Osimertinib Generics Sales Value (2021-2032)
  4. 1.2.2 Global Osimertinib Generics Sales Volume (2021-2032)
  5. 1.2.3 Global Osimertinib Generics Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Osimertinib Generics Market Dynamics
  1. 2.1 Osimertinib Generics Industry Trends
  2. 2.2 Osimertinib Generics Industry Drivers
  3. 2.3 Osimertinib Generics Industry Opportunities and Challenges
  4. 2.4 Osimertinib Generics Industry Restraints
3 Osimertinib Generics Market by Company
  1. 3.1 Global Osimertinib Generics Company Revenue Ranking in 2025
  2. 3.2 Global Osimertinib Generics Revenue by Company (2021-2026)
  3. 3.3 Global Osimertinib Generics Sales Volume by Company (2021-2026)
  4. 3.4 Global Osimertinib Generics Average Price by Company (2021-2026)
  5. 3.5 Global Osimertinib Generics Company Ranking (2024-2026)
  6. 3.6 Global Osimertinib Generics Company Manufacturing Base and Headquarters
  7. 3.7 Global Osimertinib Generics Company Product Type and Application
  8. 3.8 Global Osimertinib Generics Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Osimertinib Generics Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Osimertinib Generics Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Osimertinib Generics Market by Type
  1. 4.1 Osimertinib Generics Type Introduction
  2. 4.1.1 40mg per Tablet
  3. 4.1.2 80mg per Tablet
  4. 4.2 Global Osimertinib Generics Sales Volume by Type
  5. 4.2.1 Global Osimertinib Generics Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Osimertinib Generics Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Osimertinib Generics Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Osimertinib Generics Sales Value by Type
  9. 4.3.1 Global Osimertinib Generics Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Osimertinib Generics Sales Value by Type (2021-2032)
  11. 4.3.3 Global Osimertinib Generics Sales Value Share by Type (2021-2032)
5 Osimertinib Generics Market by Application
  1. 5.1 Osimertinib Generics Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Other
  5. 5.2 Global Osimertinib Generics Sales Volume by Application
  6. 5.2.1 Global Osimertinib Generics Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Osimertinib Generics Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Osimertinib Generics Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Osimertinib Generics Sales Value by Application
  10. 5.3.1 Global Osimertinib Generics Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Osimertinib Generics Sales Value by Application (2021-2032)
  12. 5.3.3 Global Osimertinib Generics Sales Value Share by Application (2021-2032)
6 Osimertinib Generics Regional Sales and Value Analysis
  1. 6.1 Global Osimertinib Generics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Osimertinib Generics Sales by Region (2021-2032)
  3. 6.2.1 Global Osimertinib Generics Sales by Region: 2021-2026
  4. 6.2.2 Global Osimertinib Generics Sales by Region (2027-2032)
  5. 6.3 Global Osimertinib Generics Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Osimertinib Generics Sales Value by Region (2021-2032)
  7. 6.4.1 Global Osimertinib Generics Sales Value by Region: 2021-2026
  8. 6.4.2 Global Osimertinib Generics Sales Value by Region (2027-2032)
  9. 6.5 Global Osimertinib Generics Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Osimertinib Generics Sales Value (2021-2032)
  12. 6.6.2 North America Osimertinib Generics Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Osimertinib Generics Sales Value (2021-2032)
  15. 6.7.2 Europe Osimertinib Generics Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Osimertinib Generics Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Osimertinib Generics Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Osimertinib Generics Sales Value (2021-2032)
  21. 6.9.2 South America Osimertinib Generics Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Osimertinib Generics Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Osimertinib Generics Sales Value Share by Country, 2025 VS 2032
7 Osimertinib Generics Country-level Sales and Value Analysis
  1. 7.1 Global Osimertinib Generics Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Osimertinib Generics Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Osimertinib Generics Sales by Country (2021-2032)
  4. 7.3.1 Global Osimertinib Generics Sales by Country (2021-2026)
  5. 7.3.2 Global Osimertinib Generics Sales by Country (2027-2032)
  6. 7.4 Global Osimertinib Generics Sales Value by Country (2021-2032)
  7. 7.4.1 Global Osimertinib Generics Sales Value by Country (2021-2026)
  8. 7.4.2 Global Osimertinib Generics Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Osimertinib Generics Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Osimertinib Generics Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Osimertinib Generics Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Osimertinib Generics Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Osimertinib Generics Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Osimertinib Generics Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Osimertinib Generics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Osimertinib Generics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Osimertinib Generics Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Osimertinib Generics Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Osimertinib Generics Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Osimertinib Generics Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Osimertinib Generics Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Osimertinib Generics Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Osimertinib Generics Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Osimertinib Generics Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Osimertinib Generics Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Osimertinib Generics Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Osimertinib Generics Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Osimertinib Generics Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Osimertinib Generics Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Osimertinib Generics Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Osimertinib Generics Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Osimertinib Generics Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Osimertinib Generics Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Osimertinib Generics Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Osimertinib Generics Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Osimertinib Generics Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Osimertinib Generics Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Osimertinib Generics Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Osimertinib Generics Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Osimertinib Generics Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Osimertinib Generics Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Osimertinib Generics Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Osimertinib Generics Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Osimertinib Generics Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Osimertinib Generics Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Osimertinib Generics Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Osimertinib Generics Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Osimertinib Generics Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Osimertinib Generics Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Osimertinib Generics Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Osimertinib Generics Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Osimertinib Generics Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Osimertinib Generics Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Osimertinib Generics Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Osimertinib Generics Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Osimertinib Generics Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Osimertinib Generics Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Osimertinib Generics Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Osimertinib Generics Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Osimertinib Generics Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Osimertinib Generics Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Osimertinib Generics Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Osimertinib Generics Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Osimertinib Generics Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Osimertinib Generics Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Osimertinib Generics Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Osimertinib Generics Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Osimertinib Generics Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Osimertinib Generics Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Osimertinib Generics Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Osimertinib Generics Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Osimertinib Generics Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Osimertinib Generics Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Osimertinib Generics Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Osimertinib Generics Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Osimertinib Generics Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Osimertinib Generics Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Osimertinib Generics Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Osimertinib Generics Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Osimertinib Generics Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Osimertinib Generics Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Osimertinib Generics Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Osimertinib Generics Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Osimertinib Generics Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Osimertinib Generics Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Osimertinib Generics Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Osimertinib Generics Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Osimertinib Generics Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Osimertinib Generics Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Osimertinib Generics Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Osimertinib Generics Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Osimertinib Generics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Beacon
  2. 8.1.1 Beacon Company Information
  3. 8.1.2 Beacon Business Overview
  4. 8.1.3 Beacon Osimertinib Generics Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Beacon Osimertinib Generics Product Portfolio
  6. 8.1.5 Beacon Recent Developments
  7. 8.2 Drug International
  8. 8.2.1 Drug International Company Information
  9. 8.2.2 Drug International Business Overview
  10. 8.2.3 Drug International Osimertinib Generics Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Drug International Osimertinib Generics Product Portfolio
  12. 8.2.5 Drug International Recent Developments
  13. 8.3 General Pharmaceuticals
  14. 8.3.1 General Pharmaceuticals Company Information
  15. 8.3.2 General Pharmaceuticals Business Overview
  16. 8.3.3 General Pharmaceuticals Osimertinib Generics Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 General Pharmaceuticals Osimertinib Generics Product Portfolio
  18. 8.3.5 General Pharmaceuticals Recent Developments
  19. 8.4 Pharmacil
  20. 8.4.1 Pharmacil Company Information
  21. 8.4.2 Pharmacil Business Overview
  22. 8.4.3 Pharmacil Osimertinib Generics Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Pharmacil Osimertinib Generics Product Portfolio
  24. 8.4.5 Pharmacil Recent Developments
  25. 8.5 Zydus
  26. 8.5.1 Zydus Company Information
  27. 8.5.2 Zydus Business Overview
  28. 8.5.3 Zydus Osimertinib Generics Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Zydus Osimertinib Generics Product Portfolio
  30. 8.5.5 Zydus Recent Developments
  31. 8.6 Wanbang Biopharmaceuticals
  32. 8.6.1 Wanbang Biopharmaceuticals Company Information
  33. 8.6.2 Wanbang Biopharmaceuticals Business Overview
  34. 8.6.3 Wanbang Biopharmaceuticals Osimertinib Generics Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Wanbang Biopharmaceuticals Osimertinib Generics Product Portfolio
  36. 8.6.5 Wanbang Biopharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Osimertinib Generics Value Chain Analysis
  2. 9.1.1 Osimertinib Generics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Osimertinib Generics Sales Mode & Process
  6. 9.2 Osimertinib Generics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Osimertinib Generics Distributors
  9. 9.2.3 Osimertinib Generics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst